YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)

Parker Waichman Alonso LLP Headlines by Topic

Adderall

FDA to examine new ways to study ADD drugs

Jan 4, 2006 | AP
Reports of sudden deaths, strokes, heart attacks and hypertension in both children and adults taking drugs to treat attention deficit hyperactivity...

New Warnings Due for ADHD Drugs

Jun 30, 2005 | USA TODAY
The Food and Drug Administration plans to add new warnings about psychiatric side effects to the label of Concerta and other drugs for attention...

ADHD Drug Comes Under Scrutiny From Parents

Mar 29, 2005 | AP
Parents whose children take Adderall XR for Attention-Deficit Hyperactivity Disorder (ADHD) face a dilemma :whether to let their kids stay on a...

Shire Suspends Sales Amid Safety Fears

Feb 10, 2005 | Scotsman, UK
Shire Pharmaceuticals saw its share price plunge 10% today after its best-selling drug was ordered off the shelves in Canada amid safety...

Health Canada Orders ADHD Drug Off Market After Reports of Deaths, Strokes

Feb 9, 2005 | Canadan Press
Health Canada has ordered a once-a-daytreatment for attention deficit hyperactivity disorder off the market after learning the drug has been linked...

PUBLIC ADVISORY - Health Canada Important Safety Information on ADDERALL XR(R)

Feb 9, 2005 | Health Canada
Health Canada is informing Canadians thatit has instructed Shire BioChem Inc., the manufacturer of ADDERALL XR(R) to withdraw the drug from the...

FDA Alert Sudden Death in Children

Feb 9, 2005 | www.fda.gov
Health Canada has suspended marketing of Adderall XR (extended release) from the Canadian market due to concern about reports of sudden unexplained...

Health Canada Has Suspended Market Authorization of ADDERALL XRTM (amphetamine salts), A Drug Approved for Attention Deficit Hyperactivity Disorder (ADHD) In Children

Feb 9, 2005 | Health Canada
Health Canada advises you that marketing of the Attention Deficit Hyperactivity Disorder (ADHD) drug, ADDERALL XRTM (amphetamine salts) has been...

Page 3/3 [first] [prev] 1 2 3 [next] [last]

Adderall
* Denotes required field.

Title

* First Name

* Last Name

* Email Address

* Phone Number

Cell Phone Number

Office Phone Number

Street Address

Apartment/Suite

City

State

Zip Code

Please provide the best method and times to contact you:

Date of birth of person injured
(mm-dd-yyyy):

Date you started taking the drug (mm-yyyy):

Date you stopped taking the drug (mm-yyyy):

Please describe any side effects:

Other Info:

No Yes, I agree to the Parker Waichman Alonso LLP disclaimers.Click here to review all.

Yes, I would like to receive the Parker Waichman Alonso LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Home | Defective Drugs | Medical Devices | Toxic Substances | Accidents | Product Liability | Malpractice | Diseases
Nursing Home Negligence | Food Poisoning | Other Topics | Social Security Disability | Contact
Statement of Clients' Rights | Site Map | Drug Injury Search | Vioxx | Mesothelioma | Permax | Dostinex | Composix Kugel Mesh X Large Patch
Ortho Evra | Fosamax | Personal Injury Lawyer | Fusarium Keratitis | Stevens Johnson Syndrome | Florida Personal Injury Law Firm

© 2002-2009 YourLawyer.com®. All Rights Reserved.

Please note that you are not considered a client until you have signed a retainer agreement and your case has been accepted by us.
Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Attorney Advertising

Parker Waichman Personal Injury News